Artificial intelligence is playing an increasingly important role in document management in the life sciences industry and in particular in improving management and oversight of the Trial Master File (TMF). The podcast explores why and how AI is a gamechanger for the TMF and what it means for pharmaceutical companies now and in the future. 

Jim Horstmann is Product Manager of Clinical Products at Phlexglobal where he draws on his extensive experience in document management solutions that comply with health authority regulations while also being easy to use and interoperable with other systems. For the past 11 years, Jim has focused primarily on electronic Trial Master File solutions. He is passionate about optimizing business processes by leveraging technology to help make organizations more efficient and productive.

For more information about how AI is used PhlexTMF, please visit https://www.phlexglobal.com/